What Whipped Egg Whites Can Teach Healthcare About Bubbles and Biologics

Everyone knows that eggs are a good source of protein. Fewer people stop to consider what happens to those proteins when egg whites are whipped.

Clear liquid becomes an opaque foam. Its volume expands dramatically. A structure appears where none was visible before.

The ingredients have not changed. The handling has.

What Whipping Actually Does

Whipping introduces two things at once: air and mechanical energy. As the whisk divides large pockets of air into smaller bubbles, the total surface area between air and liquid increases.

Egg-white proteins migrate toward those newly created interfaces. Parts of the protein that interact more readily with water remain oriented toward the liquid, while other regions orient toward the air. The proteins partially unfold and organize into films that surround and stabilize the bubbles.

With continued whipping, those protein films connect into a network. The familiar foam is evidence that air, motion, interfaces, and protein structure are interacting.

A useful observation
A bubble is more than empty space. It creates an interface—and the more bubbles there are, the more interface the liquid contains.

See the Science in Action

The transformation of egg whites makes the effects of air, agitation, and protein behavior easy to see. The American Egg Board video “Aeration in Baked Goods” explains how whipping introduces air, increases the number of bubbles, and causes egg-white proteins to organize around newly created air–liquid interfaces.

Aeration in Baked Goods,” presented by the American Egg Board and narrated by Shelly McKee, Ph.D., Auburn University. Selected excerpts shown: 2:26–2:50 and 7:25–8:16.

Why This Matters Beyond the Kitchen

Therapeutic proteins are not egg proteins, and medications are formulated for specific conditions of storage, preparation, and administration. The kitchen analogy cannot predict the behavior of a biologic medicine.

It can, however, make an important scientific concept easier to understand: proteins may interact with air–liquid interfaces, and agitation can continually expose more protein molecules to those interfaces.

Published biopharmaceutical research has used shaking, stirring, and bubbling as stress conditions when studying protein particles and aggregation. Results vary by molecule, formulation, container, temperature, duration, and other conditions. There is no responsible basis for saying that every bubble causes clinically meaningful damage.

There is equally little reason to assume that unnecessary bubbling is irrelevant to every protein-based medication.

A Handling Question Worth Asking

Rigid medication containers require replacement air as fluid leaves. In some administration systems, that air is introduced beneath the liquid surface and rises through the medication as bubbles.

If the air instead enters the headspace, the container can receive the pressure replacement it needs without requiring that replacement air to travel through the medication.

The reflection
If replacement air can be delivered directly to the headspace, why require it to travel through the medication?

The I2F Connection

I2F was designed to direct filtered replacement air toward the headspace of a rigid medication bottle. The concept is intended to reduce unnecessary replacement-air bubbles moving through the fluid during administration.

That design intent should not be mistaken for a clinical claim. Whether a specific medication is susceptible to a particular handling stress—and whether changing the air pathway produces a meaningful benefit—must be established through product-specific testing.

From a Familiar Foam to a Better Question

Whipped egg whites are memorable because the change is so visible. Air and motion transform a protein-containing liquid into a foam before our eyes.

Medication handling rarely offers such dramatic visual feedback. That makes it even more important to examine the interfaces and stresses built into routine workflows rather than assuming that familiar practices are automatically inconsequential.

If air, bubbles, and agitation can so visibly affect one protein-containing liquid, should we assume they are irrelevant to every other one?

Important disclosure
Egg whites and therapeutic proteins are not equivalent, and this analogy does not demonstrate damage to any medication. I2F is currently a veterinary medical device and is not cleared or approved for human use. No product compatibility, clinical effect, reduction in aggregation, reduction in immunogenicity, or patient benefit is established by this reflection. Human use would require appropriate testing, regulatory review, and authorization.

Sources and Further Reading

American Egg Board: Aeration, Foaming, and Structure. https://www.incredibleegg.org/professionals/manufacturers/real-egg-functionality/aeration-foaming-structure/

American Egg Board video: Aeration in Baked Goods. https://www.youtube.com/watch?v=JdzJizdIZYg

FDA: Immunogenicity Assessment for Therapeutic Protein Products. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/immunogenicity-assessment-therapeutic-protein-products

Li et al.: Interfacial Stress in the Development of Biologics. https://pubmed.ncbi.nlm.nih.gov/31136024/

Sreenivasan, Jiskoot, and Rathore: Bubbling-Induced Aggregation of Therapeutic Proteins. https://pubmed.ncbi.nlm.nih.gov/34224894/